Chemical and biomolecular engineers at Georgia Tech have developed a plug-and-play platform that's simple, flexible, and easy ...
NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company ...
IN8bio (INAB) unveiled INB-600, its next generation gammadelta T cell-based TCE platform. It is designed to address one of the biggest shortcomings of current existing gammadelta TCEs ...
The GEAR platform aims to enhance the effectiveness of cancer therapies by preventing NK cell neutralization, providing a promising new approach to immuno-oncology. "We are thrilled to expand our ...
(RTTNews) - IN8bio, Inc. (INAB) announced the launch of its next-generation Gamma-Delta T-cell engager or TCE platform INB-600, designed to overcome the limitations of existing Gamma-Delta TCE ...